TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹101 Cr | ₹72 Cr | ₹36 Cr | ₹25 Cr | ₹19 Cr |
What is the latest Total Expenditure of TRIDENT LIFELINE ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹101 Cr |
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹19 Cr |
How is Total Expenditure of TRIDENT LIFELINE Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹101 Cr | 40.22 | |
| Mar2025 | ₹72 Cr | 97.69 | |
| Mar2024 | ₹36 Cr | 43.14 | |
| Mar2023 | ₹25 Cr | 33.40 | |
| Mar2022 | ₹19 Cr | - | |
Compare Total Expenditure of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹500.4 Cr | -3.2% | 10.8% | 38% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -3.2% |
10.8% |
38% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses